| Sr. No. |
Name Of The Product |
Indication |
| 1 |
Azacitidine for Injection 100 mg |
Refractory anemia |
| 2 |
Bendamustine 100mg |
|
| 3 |
Bortezomib 3.5 & 2mg |
|
| 4 |
Bleomycin for Injection USP 15 Units & 30 Units |
Testicular cancer and squamous cell cancer |
| 5 |
Cabazitaxel injection 60 mg/1.5 ml along with Diluent for Cabazitaxel injection |
Hormone refractory metastatic prostate cancer |
| 6 |
Carboplatin injection BP 150 mg & 450 mg |
Advanced ovarian cancer |
| 7 |
Carmustine for Injection USP 100 mg along with Diluent for Carmustine for Injection |
Brain Tumors |
| 8 |
Cisplatin for injection USP 10 mg, 50 mg & 100 mg2 |
Metastatic testicular tumors |
| 9 |
Cladribine injection 100 mg |
Hairy cell leukemia |
| 10 |
Clofarbine |
|
| 11 |
Cyclophosphamide for Injection USP 200 mg, 500 mg & 1000 mg |
Malignant Lymphomas |
| 12 |
Cytarabine for Injection USP 100 mg, 500 mg, 1000 mg & 2000 mg |
Non-lymphocytic leukemia |
| 13 |
Daunorubicin for Injection USP 20 mg |
Acute lymphocytic leukemia |
| 14 |
Decitabine for Injection 50 mg |
Myelodysplastic syndromes |
| 15 |
Docetaxel Injection USP 20 mg, 80 mg &120 mg |
Metastatic breast cancer |
| 16 |
Doxorubicin hydrochloride for injection USP 10 mg & 50 mg |
Acute lymphoblastic leukemia & acute myeloblastic leukemia |
| 17 |
Epirubicin hydrochloride for injection 10 mg, 50 mg & 100 mg |
Certain types of Breast cancer |
| 18 |
Etoposide Injection USP 100 mg, 250 mg, 500 mg & 1000 mg |
Lung cancer and testicular cancer |
| 19 |
Fludarabine phosphate for injection USP 50 mg |
B-cell chronic lymphocytic leukemia |
| 20 |
Fluorouracil injection USP 250 mg & 500 mg |
Colon cancer and Breast cancer |
| Oncology (Injection) |
| Sr. No. |
Name Of The Product |
Indication |
| 21 |
Methotrexate injection USP 5 mg, 50 mg, 100 mg, 500 mg & 1000 mg |
Breast cancer and Epidermoid cancer |
| 22 |
Mitomycin for injection USP 2 mg, 5 mg, 20 mg & 40 mg |
Adenocarcinoma of stomach or pancreas |
| 23 |
Mitoxanthrone injection 20 mg, 25 mg & 30 mg |
Secondary progressive multiple sclerosis & Acute non-lymphocytic leukemia |
| 24 |
Oxaliplatin for injection USP 50 mg & 100 mg |
Advanced colorectal cancer |
| 25 |
Paclitaxel injection USP 30 mg, 100 mg, 150 mg, 250 mg, 260 mg & 300 mg |
Breast/Lung/Pancreati c cancer |
| 26 |
Pamidronate Disodium for injection USP 30 mg, 60 mg & 90 mg |
Hypercalcemia associated with malignancy |
| 27 |
Pemetrexed for Injection 100 mg & 500 mg |
Metastatic nonsquamous non- small cell lung cancer |
| 28 |
Temozolomide |
|
| 29 |
Thiotepa for injection USP 15 mg & 100 mg |
Adenocarcinoma of Breast and Ovaries |
| 30 |
Topotecan hydrochloride for injection 4 mg |
Metastatic carcinoma of Ovaries |
| 31 |
Vinblastine for injection 10 mg |
Testicular cancer, Squamous cell carcinoma and lymphocytic leukemia |
| 32 |
Vincristine sulfate injection USP 1mg |
Acute leukemia |
| 33 |
Vinorelbine injection USP 10 mg & 50 mg |
Advanced (or) metastatic non-small lung cell cancer |
| 34 |
Zoledronic Acid for injection 4 mg |
Multiple myeloma & Bone metastases of solid tumors |
| 35 |
Gemcitabine for injection USP 200 mg & 1000 mg |
Metastatic non-small lung cancer |
| 36 |
Idarubicin HCL Injection 5 mg & 20 mg |
Acute myeloid leukemia |
| 37 |
Ifosfamide injection USP 1000 mg & 3000 mg |
Germ cell testicular cancer |
| 38 |
Irinotecan hydrochloride injection USP 40 mg, 100 mg & 500 mg |
Colorectal cancer |
